[Advances in pulmonary pathology in China over the past ten years: retrospect and prospect].

Over the past decade, China has made remarkable achievements in the updating of molecular characteristics and diagnostic criteria of lung cancer, pathological characteristics of COVID-19, classification scheme of interstitial lung disease, application of artificial intelligence in pulmonary pathological diagnosis, and clinical application of new biomarkers such as liquid biopsy. The Chinese Journal of Pathology has witnessed a revolution in this field. On the occasion of the 70th anniversary of the journal, this article reviews the development of pulmonary pathology over the past decade and looks forward to the future trend.